tirzepatide deaths Effects of on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial Stopping GLP-1 drugs can quickly

Participants who took this medication, along with lifestyle interventions, lost significantly more weight than those who solely made lifestyle changes

Once patients stop the medication, they will likely regain the lost weight, as appetite reduction is gone

PMCID: PMC7521417

Pharmacokinetic and metabolic studies of high-dose busulphan in adults

Tirzepatide differentially induces internalization of the GIP and GLP-1 receptors with EC50 values of 18.2 nM and 18.1 nM, respectively

During the first week after your initial Wegovy shot, your body begins adjusting to the medication as it mimics natural GLP-1 hormones that help regulate appetite, digestion, and blood sugar levels